The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Cognitive Function in Breast Cancer Patients Receiving Adjuvant Chemotherapy
Abstract
PURPOSE: Breast cancer patients receiving chemotherapy have complained of difficulties in their ability to remember, think, and concentrate. This study assessed whether there are differences in cognitive function between breast cancer patients treated with standard-dose adjuvant chemotherapy compared with healthy controls. PATIENTS AND METHODS: The High Sensitivity Cognitive Screen and the Profile of Mood States (POMS) were used to assess cognitive function and mood in a group of 107 women. The women consisted of 31 breast cancer patients receiving adjuvant chemotherapy (group A), 40 breast cancer patients who had completed adjuvant chemotherapy a median of 2 years earlier (group B), and 36 healthy controls (group C). RESULTS: Univariate analysis showed statistically significant differences (P = .009) in overall cognitive function scores between groups A and C, with poorer function in patients receiving adjuvant chemotherapy. These differences remained significant (P = .046) when controlling for age, education level, and menopausal status. More patients had moderate or severe cognitive impairment in groups A and B than in controls (P ≤ .002). There were no significant differences in POMS scores between the groups, suggesting that the differences seen in cognitive scores were unlikely to be because of mood disturbance. CONCLUSION: Cognitive differences were observed in breast cancer patients receiving adjuvant chemotherapy compared with healthy controls. These differences did not seem to be caused by significant differences in mood disturbance between the two groups. If confirmed, these results have substantial implications for informed consent, counseling, and psychosocial support of patients receiving adjuvant chemotherapy for breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Landis, S. H., Murray, T., Bolden, S., & Wingo, P. A. (1998) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.48.1.6 · Cited by 2,341
Polychemotherapy for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(98)03301-7 · Cited by 2,042
Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer
Bonadonna, G., Brusamolino, E., Valagussa, P., Rossi, A., Brugnatelli, L., Brambilla, C., De Lena, M., Tancini, G., Bajetta, E., Musumeci, R., et al. (1976) · New England Journal of Medicine · doi:10.1056/nejm197602192940801 · Cited by 1,329
van Dam, F. S. A. M., Boogerd, W., Schagen, S. B., Muller, M. J., Droogleever Fortuyn, M. E., Wall, E. V. D., & Rodenhuis, S. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.3.210 · Cited by 763
Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma
Schagen, S. B., van Dam, F. S. A. M., Muller, M. J., Boogerd, W., Lindeboom, J., & Bruning, P. F. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990201)85:3<640::aid-cncr14>3.0.co;2-g · Cited by 620
Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer
Wieneke, M. H., & Dienst, E. R. (1995) · Psycho-Oncology · doi:10.1002/pon.2960040108 · Cited by 317
Cognitive deficits in patients with small cell lung cancer before and after chemotherapy
Meyers, C. A., Byrne, K. S., & Komaki, R. K. (1995) · Lung Cancer · doi:10.1016/0169-5002(95)00446-8 · Cited by 166
Psychological problems associated with diagnosis and treatment of lymphomas. II: Prospective study.
Devlen, J., Maguire, P., Phillips, P. H., & Crowther, D. (1987) · BMJ · doi:10.1136/bmj.295.6604.955 · Cited by 145
Silberfarb, P. M., Philibert, D., & Levine, P. M. (1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.5.597 · Cited by 138
Meyers, C. A., Weitzner, M. A., Byrne, K., Valentine, A., Champlin, R. E., & Przepiorka, D. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.4.820 · Cited by 136
Sitzia, J., & Huggins, L. (1998) · Cancer Practice · doi:10.1046/j.1523-5394.1998.1998006013.x · Cited by 131
A comparison of patient-reported side effects among three chemotherapy regimens for breast cancer.
Greene, D., Nail, L. M., Fieler, V. K., Dudgeon, D. J., & Jones, L. S. (1994) · PubMed · Cited by 117
Cognitive functioning in cancer patients
Meyers, C. A., & Abbruzzese, J. L. (1992) · Neurology · doi:10.1212/wnl.42.2.434 · Cited by 85
Psychologic and neuropsychologic impact of autologous bone marrow transplantation.
Ahles, T. A., Tope, D. M., Furstenberg, C. T., Hann, D. M., & Mills, L. E. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.5.1457 · Cited by 85
The Development and Initial Validation of a Sensitive Bedside Cognitive Screening Test
Faust, D., & Fogel, B. S. (1989) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198901000-00004 · Cited by 41
Cited by
Wefel, J. S., Vardy, J., Ahles, T., & Schagen, S. B. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70294-1 · Cited by 998
Candidate mechanisms for chemotherapy-induced cognitive changes
Ahles, T. A., & Saykin, A. J. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2073 · Cited by 916
(2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.13.979 · Cited by 893
Cognitive deficits in adult patients with brain tumours
Taphoorn, M. J., & Klein, M. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00680-5 · Cited by 756
Prevalence, mechanisms, and management of cancer-related cognitive impairment
Janelsins, M. C., Kesler, S. R., Ahles, T. A., & Morrow, G. R. (2014) · International Review of Psychiatry · doi:10.3109/09540261.2013.864260 · Cited by 745
Metadata
- Authors
- Brezden, C. B., Phillips, K.-A., Abdolell, M., Bunston, T., & Tannock, I. F.
- Venue
- Journal of Clinical Oncology
- Published
- 2000-07-14
- Volume
- 18
- Issue
- 14
- Pages
- 2695-2701
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1847137107
- Cited by
- 557
- References
- 15
- FWCI
- 20.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.